Although high bone turnover was infrequent in the current cohort of patients, precluding testing as to whether FGF23, DMP1, and sclerostin are affected by high bone turnover after solid organ transplantation, no relationship was noted between bone formation rate and expression of any of the osteocytic proteins, consistent with previous data in pre-dialysis CKD and dialysis patients [6,23,24]. The gene discussed is FGF23; the disease is chronic kidney disease.